share_log

Piper Sandler Initiates Coverage On Unicycive Therapeutics With Overweight Rating, Announces Price Target of $9

Piper Sandler Initiates Coverage On Unicycive Therapeutics With Overweight Rating, Announces Price Target of $9

派珀·桑德勒以增持評級啓動對Unicycive Therapeutics的報道,宣佈目標股價爲9美元
Moomoo 24/7 ·  04/04 07:03

Piper Sandler analyst Yasmeen Rahimi initiates coverage on Unicycive Therapeutics (NASDAQ:UNCY) with a Overweight rating and announces Price Target of $9.

派珀·桑德勒分析師亞斯敏·拉希米以增持評級啓動了對Unicycive Therapeutics(納斯達克股票代碼:UNCY)的報道,並宣佈目標股價爲9美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論